3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Radiodermatitis
1
Immune System Diseases
1
Breast Neoplasms
1
Interventions
Cyclophosphamide
7
fludarabine phosphate
4
Tacrolimus
4
Mycophenolic Acid
4
Busulfan
4
pembrolizumab
2
fludarabine
2
cobomarsen
2
Whole-Body Irradiation
2
Vincristine
2
Rituximab
2
Prednisone
2
Peripheral Blood Stem Cell Transplantation
2
Patient Reported Outcome Measures
2
Mesna
2
Melphalan
2
Doxorubicin
2
thymoglobulin
1
Vorinostat
1
Plasmalyte A
1
Ifosfamide
1
Etoposide
1
Dimethyl Sulfoxide
1
Carboplatin
1
Brentuximab Vedotin
1
Bone Marrow Transplantation
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 2
×
Immune System Diseases
×
Dimethyl Sulfoxide
×
Clear all
NCT02519816
2019-08-14
CARE
Maisonneuve-Rosemont Hospital
Phase 2
Unknown
17 enrolled